Targeting the Lymphatics in colorectal Liver metastasis

Lead Researcher Email Number Webpage
Christopher Christophi +61 3 9496 5967 View page
Christopher Christophi +61 3 9496 3670 View page

Project Details

Surgery is the only potentially curative treatment of colorectal liver metastases (CRLM). Lymphatic tumoural spread influences survival, studies from our group have shown that the patterns of lymphatic invasion may be associated with prognosis.

Our clinical studies show that patients with low lymphatic densities in resected tumours demonstrated a significant increase in disease free survival compared to patients with high lymphatic vessel density.

Our current project looks at measuring amounts of lymphangiogenesis (LyA) specific markers in tumour tissue/blood using microRNA techniques in patients with CRLM and correlation with prognosis.




Research Outcomes

  1. Christophi C, Nguyen L, Muralidharan V, Nikfarjam M, Banting J. “Lymphatics and colorectal liver metastases: the case for sentinel node mapping”. HPB (Oxford) 2013.
  2. Muralidharan V, Nguyen L, Banting J, Christophi C. “The prognostic significance of lymphatics in colorectal liver metastases”. HPB Surg. 2014;2014:954604.
  3. Hadj AK, Malcontenti-Wilson C, Nikfarjam M, Christophi C. Lymphatic patterns of colorectal liver metastases. The Journal of surgical research. 2012;173(2):292-8.

Research Group

Liver Group

Faculty Research Themes


School Research Themes

Cancer in Medicine

Key Contact

For further information about this research, please contact the research group leader.

Department / Centre


Unit / Centre

Liver Group